BG Medicine Announces Achievement of Two Significant Milestones for AMIPredict(TM)
May 11, 2011 08:46 ET
|
BG Medicine Inc.
WALTHAM, Mass., May 11, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today that it has successfully completed an important phase in the development of its AMIPredict™...
BG Medicine Announces First Quarter 2011 Financial Results Release Date and Conference Call Information
May 06, 2011 16:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., May 6, 2011 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the first quarter of fiscal year 2011 will be released prior to the...
BG Medicine to Present at BioCentury Future Leaders in the Biotech Industry Conference
April 12, 2011 18:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., April 12, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) will present at the BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 15, 2011. The...
Explore the Science Behind Galectin-3 With the Launch of BG Medicine's New Social Media Platforms
April 05, 2011 08:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., April 5, 2011 (GLOBE NEWSWIRE) -- BG Medicine (Nasdaq:BGMD) today announced the launch of its @galectin3 Twitter handle and galectin-3 Facebook fan page in an effort to raise awareness...
Use of Galectin-3 as a Risk Marker for Heart Failure Development to be Presented at American College of Cardiology 60th Annual Scientific Session
April 04, 2011 08:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., April 4, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that results from an initial research study of galectin-3 to identify individuals at risk for the...
BG Medicine Named to Russell 3000(R) Investment Index
April 01, 2011 08:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., April 1, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that it has been added to the Russell 3000® Index, which measures the performance of the 3,000...
BG Medicine Announces Research Agreement With Boston Scientific on Biomarkers Relevant to Congestive Heart Failure and Cardiac-Resynchronization Therapy
March 30, 2011 08:30 ET
|
BG Medicine Inc.
WALTHAM, Mass., March 30, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that it has entered into a research collaboration agreement with Boston Scientific Corporation, a...
BG Medicine Announces Availability of Galectin-3 Testing Service Through Health Diagnostic Laboratory, Inc.
March 24, 2011 08:30 ET
|
BG Medicine Inc.
WALTHAM, Mass. and RICHMOND, Va., March 24, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) and Health Diagnostic Laboratory, Inc. (HDL, Inc.), announced today an agreement under which HDL,...
BG Medicine Announces Fiscal 2010 Year End and Fourth Quarter Results
March 16, 2011 16:02 ET
|
BG Medicine Inc.
WALTHAM, Mass., March 16, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the year and quarter ended December 31, 2010 and provided...
BG Medicine Announces Fourth Quarter and Fiscal Year 2010 Financial Results Release Date and Conference Call Information
March 10, 2011 16:43 ET
|
BG Medicine Inc.
WALTHAM, Mass., March 10, 2011 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the fourth quarter and fiscal year 2010 will be released after market...